Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
There are many advantages to becoming a company advisor, but academics should think carefully about the legal and personal implications before accepting a seat on the board.
With acquisition the most likely exit for today's biotech investors, it pays to keep current with the tastes of pharmaceutical firms when launching a venture.
A survey of stakeholders in the Indian biotech sector reveals three major challenges that will need to be addressed to spark further entrepreneurial activity.